SR
Soumit Roy Jones Trading Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
48%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $21.50 |
1%
upside
| 1 | – |
–
| 6 Mar ‘26 3 days ago |
|
|
|
Buy
Initiated
| $7 |
72%
upside
| 1 | +59% |
0
%
| 22 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $7 |
141%
upside
| 1 | +128% |
0
%
| 22 Dec ‘25 2 months ago |
|
|
|
Buy
Initiated
| $10 |
225%
upside
| 1 | -46% |
0
%
| 30 Oct ‘25 4 months ago |
|
|
|
Hold
Downgraded
| – | – | 1 | – |
–
| 24 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $50 |
18%
downside
| 1 | +85% |
0
%
| 8 Sep ‘25 6 months ago |
|
|
|
Buy
Initiated
| $21 |
265%
upside
| 1 | +77% |
0
%
| 22 May ‘25 9 months ago |
|
|
|
Buy
Initiated
| $40 |
61%
upside
| 1 | +28% |
0
%
| 20 May ‘25 9 months ago |
|
|
|
Buy
Maintained
| $27 |
9%
downside
| 1 | +67% |
0
%
| 16 May ‘25 9 months ago |
|
|
|
Hold
Downgraded
| – | – | 1 | – |
–
| 16 May ‘25 9 months ago |
|
|
|
Hold
Downgraded
| – | – | 1 | – |
–
| 16 May ‘25 9 months ago |
|
|
|
Hold
Downgraded
| – | – | 1 | -3% |
–
| 25 Mar ‘25 11 months ago |
|
|
|
Buy
Upgraded
| $15 |
230%
upside
| 1 | -26% |
0
%
| 13 Mar ‘25 1 year ago |
|
|
|
Buy
Initiated
| $10 |
111%
upside
| 1 | +107% |
0
%
| 12 Mar ‘25 1 year ago |
|
|
|
Buy
Upgraded
| $34 |
23%
upside
| 1 | -3% |
0
%
| 10 Mar ‘25 1 year ago |
|